Evidence map›Paper›PMID 39687254›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2024

[Experiences and Challenges of the Ecuadorean National Advisory Commission on Serious Events Supposedly Attributable to Vaccination or Immunization, 2020-2023Experiências e desafios da Comissão Consultiva Nacional sobre Eventos Supostamente Atribuíveis à Vacinação ou Imunização graves do Equador, 2020-2023].

Daniel Simancas-Racines, Juan Marcos Parise-Vasco, Sebastián Baldeón-Espinosa, Rosa R Aguinaga, Gabriela Vinueza-Valencia, Cristina Jacome, Jeannete Zurita, Cristina Bejar, Luis Bayas, Francisco Pérez-Tasigchana and 4 more

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniel Simancas-RacinesUniversidad UTE Facultad de Ciencias de la Salud Eugenio Espejo Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC) Quito Ecuador Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito, Ecuador.
Juan Marcos Parise-VascoUniversidad UTE Facultad de Ciencias de la Salud Eugenio Espejo Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC) Quito Ecuador Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito, Ecuador.
Sebastián Baldeón-EspinosaDirección Nacional de Inmunización Ministerio de Salud Pública Quito Ecuador Dirección Nacional de Inmunización, Ministerio de Salud Pública, Quito, Ecuador.
Rosa R AguinagaComisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización Quito Ecuador Comisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización; Quito, Ecuador.
Gabriela Vinueza-ValenciaDirección Nacional de Vigilancia Ministerio de Salud Pública Quito Ecuador Dirección Nacional de Vigilancia, Ministerio de Salud Pública, Quito, Ecuador.
Cristina JacomeDirección Nacional de Inmunización Ministerio de Salud Pública Quito Ecuador Dirección Nacional de Inmunización, Ministerio de Salud Pública, Quito, Ecuador.
Jeannete ZuritaComisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización Quito Ecuador Comisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización; Quito, Ecuador.
Cristina BejarComisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización Quito Ecuador Comisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización; Quito, Ecuador.
Luis BayasAgencia Nacional de Regulación Control y Vigilancia Guayaquil Ecuador Agencia Nacional de Regulación, Control y Vigilancia, Guayaquil, Ecuador.
Francisco Pérez-TasigchanaUniversidad UTE Facultad de Ciencias de la Salud Eugenio Espejo Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC) Quito Ecuador Universidad UTE, Facultad de Ciencias de la Salud Eugenio Espejo, Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Quito, Ecuador.
Yndira AnchayhuaConsultora internacional Organización Panamericana de la Salud Quito Ecuador Consultora internacional, Organización Panamericana de la Salud, Quito, Ecuador.
Carlos Andrés Pinto-DíazOrganización Panamericana de la Salud Washington D.C. Estados Unidos de América Organización Panamericana de la Salud, Washington D.C., Estados Unidos de América.
Helvert Felipe Molina-LeónOrganización Panamericana de la Salud Washington D.C. Estados Unidos de América Organización Panamericana de la Salud, Washington D.C., Estados Unidos de América.
Gonzalo Baquero-ParetComisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización Quito Ecuador Comisión Nacional Asesora de Eventos Supuestamente Atribuibles a la Vacunación o Inmunización; Quito, Ecuador.

Funding

CGH CDC HHS U01 GH002171
6 · The paper itself

Abstract

Objective: To describe the experiences of the National Advisory Commission on Serious Events Supposedly Attributable to Vaccination or Immunization (ESAVI) implemented in Ecuador for the period 2020-2023. Methods: A report analyzing the implementation, operations, and results of the National Advisory Commission on Serious ESAVI in Ecuador was prepared. A quantitative analysis of vaccination records was carried out, as well as a qualitative analysis based on expert interviews, reflecting the direct experiences and operational challenges faced by the members of the Commission. Results: Implementation of the Commission has allowed for the systematic recording and analysis of serious ESAVIs. Of 256 reported cases, 139 were analyzed: 59% were considered coincident events; 16.6%, unclassifiable; 6.5%, indeterminate; 5%, stress-related; 3.6% as events related to a programmatic error; and 9.4% as vaccine-related, which included allergic reactions, Guillain-Barré syndrome, and thrombosis, among others. The experts highlighted the need to improve staff training and technology infrastructure, and noted that the Commission played a crucial role in monitoring vaccine safety, as well as in increasing public confidence in vaccination processes. Conclusions: The National Advisory Commission has played an essential role in vaccine safety surveillance in Ecuador by ensuring reporting, causality analysis, and investigation of serious ESAVIs. Challenges were identified and will need to be addressed to maintain public trust in immunization programs.

Indexed as

drug-related side effects and adverse reactionsEcuadorhealth policyimmunizationplanningVaccines

Identifiers

PMID39687254
PMCPMC11648176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.